Stanford University
Showing 1,301-1,350 of 1,572 Results
-
Persis S. Drell
Provost, Emerita, James and Anna Marie Spilker Professor, Professor of Materials Science and Engineering and of Physics
BioPersis Drell is the James and Anna Marie Spilker Professor in the School of Engineering, a professor of materials science and engineering, and a professor of physics. From Feb 1, 2017 to Sept. 30, 2023, Drell was the provost of Stanford University.
Prior to her appointment as provost in February 2017, she was dean of the Stanford School of Engineering from 2014 to 2017 and director of U.S. Department of Energy SLAC National Acceleratory Laboratory from 2007 to 2012.
She earned her bachelor’s degree in mathematics and physics from Wellesley College and her PhD in atomic physics from UC Berkeley. Before joining the faculty at Stanford in 2002, she was a faculty member in the physics department at Cornell University for 14 years. -
Leora Dresselhaus-Marais
Assistant Professor of Materials Science and Engineering, of Photon Science and, by courtesy, of Mechanical Engineering
Current Research and Scholarly InterestsMy group develops new methods to update old processes in metals manufacturing
-
Juliana 'Julie' Dresvina
Overseas Studies - Oxford, Bing Overseas Studies
BioI am a medievalist and cultural historian; my work combines history, literary criticism, art history, and psychology. One of my current research projects explores how people use self-narratives — creative, devotional, or non-fiction — as a form of therapeutic practice. I am also interested in how human-shaped spaces of spiritual significance, along with religious material objects, function therapeutically: from devotional manuscripts and misericord carvings to rock sanctuaries, holy wells, and thermal springs.
I have published monographs with Oxford University Press and Brill, and I teach interdisciplinary courses on cultural history, literature, psychology, and art, as well as do study skills mentoring. -
Taran Driver
Staff Scientist, SLAC National Accelerator Laboratory
BioI gained my PhD from the Blackett Laboratory Laser Consortium at Imperial College London, where my primary research project was the development of a new type of mass spectrometry for the structural analysis of protein, DNA and RNA molecules. This technology is known as two-dimensional partial-covariance mass spectrometry (2D PC MS). Here at Stanford I work at the Linac Coherent Light Source (LCLS), using the attosecond X-ray pulses produced by the newly developed XLEAP mode to study ultrafast electronic processes in molecules. We are developing and using new spectroscopic methods in the attosecond regime to observe the motion of electrons in complex molecular systems on their natural timescale. This helps us to understand how the coherent quantum dynamics of these electronic systems affect subsequent chemical motion.
-
Ron Dror
Cheriton Family Professor and Professor, by courtesy, of Structural Biology and of Molecular & Cellular Physiology
Current Research and Scholarly InterestsMy lab’s research focuses on computational biology, with an emphasis on 3D molecular structure. We combine two approaches: (1) Bottom-up: given the basic physics governing atomic interactions, use simulations to predict molecular behavior; (2) Top-down: given experimental data, use machine learning to predict molecular structures and properties. We collaborate closely with experimentalists and apply our methods to the discovery of safer, more effective drugs.
-
David Drover
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD), Emeritus
Current Research and Scholarly InterestsField of clinical pharmacology. This involves analysis of what the body does to a drug (pharmacokinetics) and how exactly a specific drug affects the body (pharmacodynamics). His research starts at the level of new drug development with detailed analysis of the pharmacokinetics and pharmacodynamics of a medication.
-
Shaul Druckmann
Associate Professor of Neurobiology, of Psychiatry and Behavioral Sciences and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsOur research goal is to understand how dynamics in neuronal circuits relate and constrain the representation of information and computations upon it. We adopt three synergistic strategies: First, we analyze neural circuit population recordings to better understand the relation between neural dynamics and behavior, Second, we theoretically explore the types of dynamics that could be associated with particular network computations. Third, we analyze the structural properties of neural circuits.
-
Maurice L. Druzin
Professor of Obstetrics and Gynecology (Maternal Fetal Medicine and Obstetrics), Emeritus
Current Research and Scholarly InterestsAntepartum and intrapartum fetal monitoring Prenatal diagnosis Medical complications of pregnancy, particularly: SLE, hypertension, diabetes, malignancy A.
-
Tianwei Du
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Du's clinical interests focus on providing evidence-based treatment to individuals with emotion dysregulation, interpersonal difficulties, and/or complex trauma. She is also passionate about addressing diversity factors in clinical work. Dr. Du provides services in the Dialectical Behavior Therapy (DBT) Adult Program, Stanford Mental Health for Asians Research and Treatment (SMHART) Clinic, and the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic. Dr. Du is a bilingual clinician speaking English and Mandarin.
Dr. Du's research focuses on exploring the roles of interpersonal processes and personality in psychopathology, and she has published widely on this topic. Dr. Du also participated in a variety of clinical trials to help develop and improve evidence-based interventions for individuals with complex clinical presentations and populations with limited access to mental health care. -
Justin Du Bois
Henry Dreyfus Professor of Chemistry and Professor, by courtesy, of Chemical and Systems Biology
BioResearch and Scholarship
Research in the Du Bois laboratory spans reaction methods development, natural product synthesis, and chemical biology, and draws on expertise in molecular design, molecular recognition, and physical organic chemistry. An outstanding goal of our program has been to develop C–H bond functionalization processes as general methods for organic chemistry, and to demonstrate how such tools can impact the logic of chemical synthesis. A second area of interest focuses on the role of ion channels in electrical conduction and the specific involvement of channel subtypes in the sensation of pain. This work is enabled in part through the advent of small molecule modulators of channel function.
The Du Bois group has described new tactics for the selective conversion of saturated C–H to C–N and C–O bonds. These methods have general utility in synthesis, making possible the single-step incorporation of nitrogen and oxygen functional groups and thus simplifying the process of assembling complex molecules. To date, lab members have employed these versatile oxidation technologies to prepare natural products that include manzacidin A and C, agelastatin, tetrodotoxin, and saxitoxin. Detailed mechanistic studies of metal-catalyzed C–H functionalization reactions are performed in parallel with process development and chemical synthesis. These efforts ultimately give way to advances in catalyst design. A long-standing goal of this program is to identify robust catalyst systems that afford absolute control of reaction selectivity.
In a second program area, the Du Bois group is exploring voltage-gated ion channel structure and function using the tools of chemistry in combination with those of molecular biology, electrophysiology, microscopy and mass spectrometry. Much of this work has focused on studies of eukaryotic Na and Cl ion channels. The Du Bois lab is interested in understanding the biochemical mechanisms that underlie channel subtype regulation and how such processes may be altered following nerve injury. Small molecule toxins serve as lead compounds for the design of isoform-selective channel modulators, affinity reagents, and fluorescence imaging probes. Access to toxins and modified forms thereof (including saxitoxin, gonyautoxin, batrachotoxin, and veratridine) through de novo synthesis drives studies to elucidate toxin-receptor interactions and to develop new pharmacologic tools to study ion channel function in primary cells and murine pain models.
